Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System

作者：Kaidi Zhao, Shengxiang Xiao, Yang Zhao, Chingkuang Tu · 发表于：International Journal of Clinical Pharmacy · 年份：2025 · DOI：10.1007/s11096-025-01896-1 · 被引用次数：15 · 研究领域：Psoriasis: Treatment and Pathogenesis、Pharmacovigilance and Adverse Drug Reactions、Rheumatoid Arthritis Research and Therapies